Muenchener Rueckver Ges (MURGY) Stock Price & How to Invest

MURGY is the ticker for Munich Re's American depositary receipt, which trades over the counter in the US rather than on the NYSE or Nasdaq. It is an unsponsored ADR, meaning a depositary bank created it without a formal listing agreement with the company. Each ADR represents a fraction of one ordinary share listed in Frankfurt under the symbol MUV2, so the ADR price is much lower than the euro share price. MURGY gives US investors exposure to the same company, the same earnings and the same dividends, converted into dollars. Because it is an OTC instrument, trading volumes are lower than on the home market and bid-ask spreads can be wider, which matters most for larger orders. Some brokers also offer direct access to the Frankfurt or Xetra shares, which carry their own currency conversion and commission costs.

Munich Re earns money in two main ways. First, it collects premiums for taking on risk, from other insurers in reinsurance and from individuals and businesses through ERGO, and aims to pay out less in claims and expenses than it collects. That underwriting margin is measured by the combined ratio, where anything below 100% is profitable; Munich Re's property and casualty reinsurance has typically targeted the low to mid 80s. Second, it invests the premiums it holds before claims are paid, a pool of roughly ~€230bn to €250bn, mostly in high-quality bonds. Investment income has risen as interest rates moved up from the near-zero levels of the 2010s. Life and health reinsurance adds a steadier, longer-dated profit stream. In 2025 these combined to a net result of ~€6.1bn, the largest in the company's history at the time.

Munich Re reported a first-half 2026 net result of ~€3.9bn, up from ~€3.2bn a year earlier, with ~€2.2bn of that coming in the second quarter. Reinsurance generated ~€3.4bn of the half-year profit and ERGO ~€556m. The improvement was driven mainly by lower-than-expected major losses and strong investment income. Management kept its full-year net result target of ~€6.3bn, which implies a second half below the first, a normal assumption given that the North Atlantic hurricane season falls in the third quarter. It did lower its insurance revenue outlook to ~€62bn for the group and ~€38bn for reinsurance, reflecting both currency effects from a stronger euro and the company's decision to shrink in segments where it felt prices no longer justified the risk. Third-quarter results are typically published in early November.

Munich Re pays one dividend a year, after its annual general meeting in late April or early May. For the 2025 financial year, shareholders approved ~€24 per ordinary share, up from ~€20 the year before. MURGY holders receive a proportional amount per ADR, converted into dollars, so the per-ADR payment is a small fraction of €24 and its dollar value depends on the exchange rate on the conversion date. Germany withholds tax on dividends at a headline rate of about 26.4%, and US investors can often reclaim part of that or credit it against US tax, though the process can be slow. Depositary banks may also deduct a small per-ADR fee. At a home-share price in the region of €450 to €500, the €24 payout implies a yield of roughly ~5% before taxes and fees.

On standard measures, Munich Re trades at a modest valuation: roughly 9 to 10 times trailing earnings and around 10 to 11 times its 2026 profit target, with a dividend yield near ~5% and a buyback adding a few more percent of shareholder return. Its return on equity of ~18% is high for a large insurer. The market applies that discount because reinsurance profits are cyclical and exposed to catastrophes that can wipe out a quarter's earnings without warning, and because the pricing cycle is softening. Whether that discount is too large or about right depends on how one weighs a decade of disciplined underwriting against the risk of a severe loss year. Comparing MURGY with Swiss Re, Hannover Re and Allianz on earnings multiple, payout and return on equity is the usual way investors frame the question.

Natural catastrophes are the biggest swing factor in Munich Re's results. The company budgets a major-loss allowance each year, typically around ~13% to 14% of reinsurance property and casualty revenue, and reports whether actual losses came in above or below it. A light catastrophe year, as in the first half of 2026, lets profits beat plan; a heavy one, such as a major US hurricane landfall or a large earthquake, can consume billions of euros. The company manages this by spreading exposure across regions, buying its own retrocession protection and pricing catastrophe risk with higher attachment points than it accepted before 2023. Climate change is pushing up the frequency of secondary perils such as floods, hail and wildfires, which are harder to model. Munich Re also publishes some of the industry's most cited annual natural catastrophe loss statistics.

Owning MURGY adds a few layers on top of the business risk. Currency is the most important: Munich Re reports in euros, so if the dollar strengthens, the dollar value of the shares and the dividend falls even if the business does well, and the reverse helps. Liquidity on the OTC market is thinner than in Frankfurt, which can mean wider spreads. As an unsponsored ADR, MURGY involves no direct company participation, so shareholder communications and voting rights may be limited, and depositary fees can be deducted from dividends. German withholding tax applies to dividends and may require paperwork to recover. Finally, OTC ADRs are not supported by every broker for every account type, and some platforms do not offer fractional trading in them. None of these changes the company's fundamentals, but they shape the experience of holding it.

Ambition 2030 is the five-year strategy Munich Re presented in early 2026, succeeding Ambition 2025, under which EPS grew ~18.8% a year on average and return on equity reached ~18.3%. The new plan targets average EPS growth above ~8% a year through 2030, a return on equity above ~18%, and a total payout ratio (dividends plus buybacks) rising above ~80% of earnings. The lower growth target versus the last cycle reflects a starting point of already elevated profits and a softening reinsurance market, rather than a weaker business. Priorities include maintaining underwriting discipline at renewals, growing specialty lines such as cyber, using data and AI in underwriting and claims, and improving ERGO's profitability. Delivery against these targets, tracked quarterly through the net result and annually through the dividend, is how the market will judge management over the plan period.